Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized Phase III pivotal trial of AT-100

Next Previous
X
Search
Trial Profile

A randomized Phase III pivotal trial of AT-100

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 25 Jun 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Zelpultide alfa (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Registrational; Therapeutic Use
  • Sponsors Airway Therapeutics

    • Most Recent Events

    • 24 Jun 2024 According to an Airway Therapeutics media release, Company plans to initiate a multinational pivotal trial of zelpultide alfa (rhSP D) in Q4 2024 beginning in Europe.
    • 05 Jun 2023 According to an Airway Therapeutics media release, company expects to begin a Phase 3 trial by end of 2023 and which will involve at least 80 hospitals in North America and across Europe.
    • 31 Mar 2022 According to an Airway Therapeutics media release, results of this trial are expected as soon as 2Q 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top